BMC, a TMR-based vaccine manufacturer, has cancelled a contract with American biotech firm Novavax almost five years to the ...

In the closing of the recent trading day, Novavax (NVAX) stood at $7.91, denoting a -0.57% change from the preceding trading day.

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from ...

Vaccine Research Market Governments and private entities are heavily investing in vaccine research and development.US, NY, UNITED STA ...